Latest News

09.23.20

Nicox Selects 0.1% NCX 470 Dose in Adaptive Stage of Mont Blanc Phase 3 Glaucoma Trial

Source: Nicox

09.23.20

Fauci Offers Defense of Why Americans Can Trust the Approval Process for a Potential COVID-19 Vaccine

Source: FierceHealthcare

09.23.20

Johnson & Johnson Starts Phase 3 Study of COVID-19 Vaccine Candidate

Source: Bloomberg

09.22.20

Lumenis Unveils Its First US Tour With Launch Of Mobile Outdoor Tradeshow Booth

Source: Lumenis

09.22.20

Analysis: Ambulatory Surgery Centers Reduce Medicare Costs by More than $4 Billion Each Year

Source: Ambulatory Surgery Center Association

09.22.20

CooperVision Recaps Complimentary Contact Lens Program for Essential Hospital Workers

Source: CooperVision

09.22.20

Moody’s: Hospital Financial Outlook Worse as COVID-19 Relief Funds Start to Dwindle

Source: FierceHealthcare

09.21.20

Biomarker Indicating Neurodegeneration Identified in the Eye

Source: Boston Medical Center

09.21.20

Liminal BioSciences Provides Update on Progress on BLA for Ryplazim (Plasminogen)

Source: Liminal BioSciences

09.21.20

Roche’s Actemra/RoActemra Cuts Need for Ventilator Use in COVID-19 Pneumonia

Source: FirstWord

View more stories